Paasa Logo
Emergent BioSolutions Inc. logo
EBSNYSEMarket closedOpens 9:30am ET

Emergent BioSolutions Inc.

$6.79Last updated
+$0.02 (0.30%)Past day
Timezone

Emergent BioSolutions Inc. (NYSE: EBS) is trading at $6.79, about ₹651 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 0.30% today. Indian residents can buy Emergent BioSolutions from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$6.76
Previous close:$6.77
Volume:631.36K

Today's low

$6.67

Today's high

$6.85

52 week low

$4.36

52 week high

$14.06

EBS opened at $6.76, closed previously at $6.77, and has traded between $4.36 and $14.06 over the past 52 weeks.

About

Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These threats encompass accidental, deliberate, and naturally occurring events, including chemical, biological, radiological, nuclear, and explosives (CBRNE) incidents, emerging infectious diseases, travel-related health risks, and acute emergency care situations. The company's current product portfolio features essential vaccines and treatments such as BioThrax for anthrax and ACAM2000 for smallpox. It also offers Botulism Antitoxin Heptavalent, vaccinia immune globulin intravenous to manage smallpox vaccine complications, and inhalational anthrax therapies like raxibacumab and Anthrasil. Other key offerings include reactive skin decontamination lotion kits, the Trobigard combination drug-device auto-injector, NARCAN nasal spray for emergency opioid overdose reversal, Vivotif, an oral typhoid fever vaccine, and Vaxchora, a single-dose oral cholera vaccine. Emergent is also actively engaged in developing a robust pipeline of future solutions. This includes AP003 (a multidose naloxone nasal spray), AP007 (a sustained-release nalmefene injection for opioid use disorder), AV7909 (an anthrax vaccine), CGRD-001 (a pralidoxime chloride/atropine auto-injector), CHIKV VLP (a chikungunya virus vaccine), COVID-HIG (for SARS-CoV2 treatment), EGRD-001 (a diazepam auto-injector), SIAN (a cyanide poisoning antidote), and UniFlu (a universal influenza vaccine). Furthermore, the company extends its expertise through comprehensive contract development and manufacturing services (CDMO). These services cover drug substance and product manufacturing, packaging, along with technology transfer and advanced process and analytical development. Emergent BioSolutions Inc., founded in 1998, is headquartered in Gaithersburg, Maryland.

Country
US
CEO
Joseph C. Papa Jr.
Exchange listed on
NYSE
Industry
Drug Manufacturers - Specialty & Generic
Base currency
USD
Full Time Employees
900
Sector
Healthcare
IPO date
15/11/2006

Key statistics

Avg. volume

1.07M

Market cap

$350.34M

P/E Ratio

-1.97

Price-to-sales ratio

0.45

Enterprise value

$792.44M

Free cash flow yield

24.52%

Debt-to-equity ratio

1.70

Return on equity

-35.91%

ROIC

-5.47%

Beta

2.34

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$742.90M

Earnings per share

$0.98

Free cash flow

$156.80M

Net profit margin

-22.96%

Gross margin

49.40%

EBITDA

$240.40M

Revenue growth

-28.81%

Similar securities

This is not an investment recommendation

How to buy Emergent BioSolutions from India

Indian residents can buy Emergent BioSolutions shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Emergent BioSolutions and place an order

    Find Emergent BioSolutions by name or by its ticker, EBS, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Emergent BioSolutions trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Emergent BioSolutions position in USD and INR. Emergent BioSolutions pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Emergent BioSolutions from India

Trading and taxes when buying Emergent BioSolutions from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneEmergent BioSolutions does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Emergent BioSolutions stock?

Yes. Emergent BioSolutions (EBS) has been listed on the New York Stock Exchange since 2006, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Emergent BioSolutions share cost in rupees?

One Emergent BioSolutions share is $6.79 — about ₹651 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Emergent BioSolutions price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Emergent BioSolutions from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Emergent BioSolutions?

Yes. One Emergent BioSolutions share is $6.79, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Emergent BioSolutions.

How are gains on Emergent BioSolutions shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Emergent BioSolutions price. Paasa issues a capital-gains statement for your return.

Does Emergent BioSolutions pay a dividend?

No. Emergent BioSolutions does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Emergent BioSolutions from India?

The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Emergent BioSolutions shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Emergent BioSolutions shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Emergent BioSolutions holding, its cost and its closing value.

How do I sell Emergent BioSolutions and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.